Live Breaking News & Updates on Mcy 0141 For

Stay updated with breaking news from Mcy 0141 for. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-News: Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis

EQS-News: Imcyse SA / Key word(s): Study Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of ImotopeTM IMCY-0141 for the Treatment of Multiple Sclerosis 13.09.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Imcyse Announces Complet. ....

Region Flamande , Denis Bedoret , Andrew Mackie , Anne Hennecke Lydia Robinson Garcia , Jean Van Rampelbergh , Chuck Padala , Mc Services , Catholic University Of Leuven , Distribution Services , Data Monitoring Committee , Announces Completion , Multiple Sclerosis , Van Rampelbergh , Independent Data Monitoring Committee , Myelin Oligodendrocyte Glycoprotein , Catholic University , Media Inquiries , Corporate News , Regulatory Announcements , Mcy 0141 For , Et Cest ,

DGAP-News: Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis

DGAP-News: Imcyse SA / Key word(s): Study 13.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement. Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of ImotopeTM IMCY-0141 for Multiple Sclerosis IMCY-MS-001 study aims to determine safe. ....

Walloon Region , Waals Gewest , Region Flamande , Denis Bedoret , Anne Hennecke Julia Bittner , Patrick Vermersch , Jonathan Nugent , Andrew Mackie , Mc Services , University Of Lille , Catholic University Of Leuven , Distribution Services , Announces First Patient Dosed , Myelin Oligodendrocyte Glycoprotein , Catholic University , Media Inquiries , Corporate News , Regulatory Announcements , Adaptive Phase , Mcy 0141 For , Mcy Ms 001 ,